Company: SVREW
Filing Date: 2025-03-31
Form Type: F-1
Source: 0001213900-25-026309
Chunk: 24

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-31
Form: F-1
Chunk 24
---
 new information, future events, changed circumstances or any other reason.

<div align='center'>12

USE OF PROCEEDS</div>

All Ordinary Shares represented by ADSs offered by this prospectus are being registered for the account of the Selling Shareholders identified herein. We will not receive any of the proceeds from the sale of these Ordinary Shares represented by the ADSs; however, we may receive proceeds from any cash exercise of the Investor Warrants and the Placement Agent Warrants, if any, for a maximum of approximately $3,607,300, if all Warrants are exercised by cash.

We intend to use any proceeds received by us from the cash exercise of the Warrants for working capital purposes. As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to us from the cash exercise of the Warrants. Accordingly, our management will have broad discretion in the timing and application of these proceeds. The holders of the Warrants may exercise their Warrants at their own discretion and at any time until their expiration, subject to, and in accordance with, the terms of the warrants. As a result, we cannot predict when or if any of the Warrants will be exercised, and it is possible that the Warrants may expire and never be exercised. In addition, the Warrants are exercisable on a cashless basis if at the time of exercise there is no effective registration statement registering, or the prospectus contained therein is not available for, the issuance of the ADSs for which the Warrants are exercisable. As a result, we may never receive meaningful, or any, cash proceeds from the exercise of the Warrants.

<div align='center'>CAPITALIZATION</div>

The following table sets forth our total capitalization as of December 31, 2024:

| ● | on an actual basis; |

| ● | on pro forma basis, after giving effect to the issuance and sale of 130,620,000 Ordinary Shares represented by 108,850 ADSs (after giving retroactive effect to the new ratio of 1,200 Ordinary Shares for each ADS) for gross proceeds of approximately $0.81 million, which have been issued to Yorkville pursuant to the standby equity purchase agreement dated July 16, 2024, as amended, as if the sale of the securities had occurred on December 31, 2024, as well as the issuance and sale of 195,428,970 Ordinary Shares represented by 162,899